18.11.2011EUSA Pharma Announces FDA Approval Of Orphan Drug ERWINAZE™ For Treatment Of Acute Lymphoblastic Leukemia

Press Release
18.11.2011Biocartis completes EUR 71 million (USD 100 million) Series C Fund Raising

Press Release
18.10.2011Cellnovo receives 2011 Best MedTech Fundraiser Award

Press Release
04.10.2011Frost & Sullivan has announced Cellnovo the winner of its 2011 European Technology Innovation Award in Diabetes Care

Press Release
19.09.2011Cellnovo Receives CE Mark Approval for World's First Mobile Diabetes Management System

Press Release
12.09.2011Cellnovo forms worldwide technology alliance with LifeScan

Press Release
01.09.2011Biocartis named as a Technology Pioneer 2012 by the World Economic Forum

Press Release
02.07.2011Cellnovo inVivo Article

In The News
10.06.2011Avila Therapeutics agreement with NIAID

Avila Therapeutics, Inc announces Non-Clinical Evaluation Agreement

Press Release
06.06.2011Positive Outcome for Algeta in Pivotal Alpharadin Study

Positive outcome of Interim Analysis of pivotal Alpharadin study: Primary endpoint met in Phase III ALSYMPCA study

Press Release